EARLY RELEASE: Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021

Published on January 7, 2022

This report describes how effective Pfizer-BioNTech COVID-19 vaccination was against multisystem inflammatory syndrome in children (MIS-C).

Continue reading on website
Other news

SURVEILLANCE SUMMARIES: Suicidal Thoughts and Behaviors Among Adults Aged ≥18 Years - United States, 2015-2019

January 6, 2022
2015-2019 National Survey on Drug Use and Health data regarding national-, regional-, and state-level prevalence of suicidal thoughts, planning, and attempts.

WHO guideline on health workforce development, attraction, recruitment and retention in rural and remote areas

January 11, 2022
An update of the WHO guideline Increasing access to health workers in remote and rural areas through improved retention. WHO